首頁 › 瀰漫性大B細胞淋巴瘤 › 加州 › Los Angeles
Los Angeles, CA 的 瀰漫性大B細胞淋巴瘤 臨床試驗
17 項針對 瀰漫性大B細胞淋巴瘤 的研究正在 Los Angeles（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
招募中2 期
- Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles, Los Angeles
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
招募中2 期
- Cedars-Sinai Medical Center, Los Angeles
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
招募中3 期
- Cedars-Sinai Medical Center ( Site 0115), Los Angeles
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
招募中3 期
- David Geffen School of Medicine at UCLA, Los Angeles
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
招募中1 期
- University of California, Los Angeles (UCLA) - Medical Center, Los Angeles
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
招募中1/2 期
- Children's Hospital Los Angeles ( Site 1006), Los Angeles
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
招募中2 期
- Valkyrie Clinical Trials, Los Angeles
A Study of ARC-02 in B-cell NHL
招募中1 期
- Start Cala, Los Angeles
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
招募中1/2 期
- Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles (UCLA) Medical Center, Los Angeles
Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies
招募中1 期
- Cedars-Sinai Medical Center, Los Angeles
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
招募中1/2 期
- Valkyrie Clinical Trials, Los Angeles
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
招募中3 期
- Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles (UCLA), Los Angeles
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
招募中1 期
- START Los Angele, Los Angeles
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
招募中1/2 期
- Los Angeles Cancer Network, Los Angeles
- UCLA Medical Center of Hematology/Oncology, Los Angeles
Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma
招募中1/2 期
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
招募中2 期
- Cedars Sinai Medical Center, Los Angeles
A Study of NX-1607 in Adults With Advanced Malignancies
招募中1 期
- University of Southern California, Los Angeles
其他城市的 瀰漫性大B細胞淋巴瘤 試驗
- New York City, NY21 項研究
- Baldwin Park, CA19 項研究
- Chicago, IL18 項研究
- Houston, TX17 項研究
- Milwaukee, WI16 項研究
- Boston, MA16 項研究
- Nashville, TN15 項研究
- Philadelphia, PA15 項研究
- Portland, OR15 項研究
- Durham, NC14 項研究
- Dallas, TX13 項研究
- Seattle, WA12 項研究
Los Angeles 的其他研究
- 非小細胞肺癌87 項研究
- 癌症（所有類型）74 項研究
- 乳癌73 項研究
- 前列腺癌61 項研究
- 大腸直腸癌59 項研究
- 轉移性癌症57 項研究
- 卵巢癌50 項研究
- 肺癌45 項研究
- 頭頸部鱗狀細胞癌42 項研究
- 胰臟癌35 項研究
- 子宮內膜癌34 項研究
- 黑色素瘤34 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。